Abivax (ABVX) Net Cash Flow (2024 - 2026)
Abivax (ABVX) posted quarterly Net Cash Flow of -$58.5 million for Q1 2026, down 38.87% year-over-year from -$95.7 million in Q1 2025, and up 33.46% quarter-over-quarter from -$87.9 million in Q4 2025.
Abivax (ABVX) Net Cash Flow (2024 - 2026) Analysis & Trends
Abivax's Net Cash Flow history runs 3 years deep, the most recent figure standing at -$58.5 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 38.87% year-over-year to -$58.5 million; the TTM figure through Mar 2026 stood at $432.2 million (up 390.71% YoY), while the FY2025 annual figure was $440.0 million, up 473.99% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$58.5 million, up from -$87.9 million in the prior quarter.
- The five-year high for Net Cash Flow was $626.0 million in Q3 2025, with the low at -$87.9 million in Q4 2025.
- The 3-year median for Net Cash Flow is -$42.1 million (2025), against an average of $30.1 million.
- Peak annual rise in Net Cash Flow reached 1527.7% in 2025, while the deepest fall reached 232.67% in 2025.
- Abivax's Net Cash Flow stood at -$41.4 million in 2024, then plunged by 112.09% to -$87.9 million in 2025, then soared by 33.46% to -$58.5 million in 2026.
- Business Quant data shows ABVX's Net Cash Flow at -$58.5 million in Q1 2026, -$87.9 million in Q4 2025, and $626.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -58.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.48 Mn |
| Mar 31, 2026 | -58.48 Mn |
| Dec 31, 2025 | -87.89 Mn |
| Dec 31, 2025 | -87.89 Mn |
| Sep 30, 2025 | 625.98 Mn |
| Sep 30, 2025 | 625.98 Mn |
| Jun 30, 2025 | -47.45 Mn |
| Jun 30, 2025 | -47.45 Mn |
| Mar 31, 2025 | -42.11 Mn |
| Mar 31, 2025 | -42.11 Mn |
| Dec 31, 2024 | -41.44 Mn |
| Dec 31, 2024 | -41.44 Mn |
| Sep 30, 2024 | -43.85 Mn |
| Sep 30, 2024 | -43.85 Mn |
| Jun 30, 2024 | -21.26 Mn |
| Jun 30, 2024 | -21.26 Mn |
| Mar 31, 2024 | -12.66 Mn |
| Mar 31, 2024 | -12.66 Mn |